Fig. 6From: Oxyresveratrol attenuates bone resorption by inhibiting the mitogen-activated protein kinase pathway in ovariectomized ratsMicro-CT analysis of the femurs in oxyresveratrol (OR)-administered rats. The femurs were analyzed after oral administration of the OR to rats of each group for 8 weeks. (a) It was confirmed that bone density was significantly lower in the OVX group, and an increase in bone density was observed at 10 and 20 mg/kg (b) Bone volume per total volume(BV/TV) result obtained by oral administration of OR. Data represent the mean ± SEM of experiments, n = 5; *p < 0.05, **p < 0.01 compared with the OVX group. Error bars indicate standard deviation. BV/TV; trabecular separationBack to article page